rekrunner wrote:
Armstronglivs wrote:
Since you have no data on EPO you have nothing to base your comparison on. But athletes who dope do. I realise the perceptions of those who aren't you are beyond your ability to comprehend.
As you can see by what you quoted, I do have data for comparison:
- the Scottish/Kenyan trials give us data on EPO of 5.6% and 4.7% respectively
- the sports scientists that hi-lo training data of 1 minute per 5km, courtesy of you
We don't have data from athletes, so nothing to base your comparison on.
If we did, athletes who dope are not blinded, nor do they control their measurements, so their data would have to be interpreted with caution (*).
In any case, we are not talking about athletes' perceptions, but yours.
You are not an athlete, and you don't seem to possess any particularly special knowledge on these topics.
You argue, irrationally and illogically, that all athletes are rational, and therefore prevalence is proof of benefit.
(*) This is also the case with the Scottish/Kenyan data on EPO, and the altitude data is likely not blinded either -- as they are not blinded, and not controlled, all of the data from EPO, altitude, and athletes, could be over-estimated).
It took a long while to say it, but you don't have data from doped athletes on which to base your apparently baseless claims about the effects of doping on performance. Thank you.